What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson’s disease? A preliminary pharmacoepidemiologic study

Treatment of Intermittent Explosive Disorder With Carbamazepine

(2018) Fatma Coskun et al.   CLINICAL NEUROPHARMACOLOGY

Impulse control disorders in Parkinson’s disease

(2018) Ana Marques et al.   JOURNAL OF NEURAL TRANSMISSION

Impulse-Control Disorders in Parkinson’s Disease: A Meta-Analysis and Review of Case–Control Studies

(2018) Helge Molde et al.   Frontiers in Neurology

Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study

(2017) Roberta Biundo et al.   MOVEMENT DISORDERS

Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release

(2017) Romina Pes et al.   NEUROPHARMACOLOGY

Impulsivity and aggression in schizophrenia: a neural circuitry perspective with implications for treatment

(2015) Matthew J. Hoptman   CNS SPECTRUMS

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

(2015) Philip Seeman   SYNAPSE

Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study

(2014) K. Papay et al.   NEUROLOGY

Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs

(2014) Thomas J. Moore et al.   JAMA Internal Medicine

Dopamine Agonist Withdrawal Syndrome: Implications for Patient Care

(2013) Melissa J. Nirenberg   DRUGS & AGING

Aggressive and impulsive behavior in Alzheimer’s disease and progression of dementia

(2013) Leszek Bidzan et al.   MEDICAL SCIENCE MONITOR

Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine

(2011) R.A. Walsh et al.   MOVEMENT DISORDERS

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

Impulse control disorders in Parkinson's disease

(2011) Dolores Vilas et al.   PARKINSONISM & RELATED DISORDERS

Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO

(2011) Romina Mizrahi et al.   SCHIZOPHRENIA RESEARCH

Impulse Control Disorders: Updated Review of Clinical Characteristics and Pharmacological Management

(2011) Liana Schreiber et al.   Frontiers in Psychiatry

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study

(2010) Daniel Weintraub et al.   ANNALS OF NEUROLOGY

Pathological gambling in Parkinson disease is reduced by amantadine

(2010) Astrid Thomas et al.   ANNALS OF NEUROLOGY

Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder

(2009) Bernardo Dell'Osso et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients With Intermittent Explosive Disorder

(2009) Emil F. Coccaro et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy of Quetiapine for Impulsivity and Affective Symptoms in Borderline Personality Disorder

(2009) Frédérique Van den Eynde et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers

(2008) Timothy Fong et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR